E-DRUG: Scientific Conference on Medicines Regulation in Africa: 2-3 Dec 2013
------------------------------------------------------------------------
[Quality of essential medicines remains a big topic. WHO Prequalification can be seen as a temporary fix to enable the international donors to procure good quality products for HIV/AIDS, TB, malaria, reproductive health and neglected diseases with confidence. This process however does not cover 'normal' essential medicines.
The only long-term sustainable solution is for Africa's Drug Regulatory Authorities to efficiently collaborate, exchange information, and become strict on medicines quality, clean its markets from substandard and falsified medicines and support companies with GMP producing good quality, evidence based products. Do submit an abstract! WB]
Dear Respected Colleagues,
The NEPAD Agency in collaboration with the World Health Organization (WHO) and the organisational support of US-Food and Drugs Administration (USFDA) and the Drugs for Neglected Diseases initiative (DNDi) is pleased to announce the First Biennial Scientific Conference on Medicines Regulation in Africa, to take place on 2 and 3 December 2013, at Birchwood Hotel, Johannesburg, South Africa. The theme of the conference is "Building Partnerships for Sustainable Capacity Development in Medicines Regulation in Africa".
The initiative to organise this conference is borne of the necessity for African regulatory authorities, researchers, academic institutions and industry to work together to address some of the salient issues affecting their areas of delivery of medical products and technologies to the public. It is undisputable fact that most of the African pharmaceutical markets are poorly regulated which consequently puts public health at risk and erodes public confidence on health care delivery systems and specifically on the quality and safety of medicines they use. In recognition of this problem, various Governments and partners have embarked on regulatory capacity building programmes albeit in uncoordinated fashion. In addition, various Regional Economic Communities (RECs) in Africa have embarked on medicines regulation harmonization initiatives with a view to increase patients' access to quality, safe and efficacious essential medicines through capacity building programmes and streamlining regulatory processes and procedures.
The objectives of the scientific conference are to:
1. Provide a forum to share scientific advances and current best practices in regulatory science disciplines amongst policy makers, regulators, industry and scientists
2. Review current global developments in the regulatory environment and assess their impact on the commercialization of health research products as part of implementation of the Pharmaceutical Manufacturing Plan for Africa (PMPA).
3. Contribute to global knowledge on regulatory science
4. Provide inputs to the third African Medicines Regulatory Authorities Conference
Call for Abstracts
The Organizing Committee requests submission of abstracts from interested parties, for presentation at the conference or publication in a Book of Abstracts. Regulators, researchers, academic institutions and regulatory scientists are invited to submit abstracts as below.
The scientific conference topics for which the call for abstracts shall be submitted are:
1. Global regulatory environment: Where is Africa?
2. Regulatory capacity development & partnerships
3. Strengthening pharmacovigilance systems in Africa
4. Providing an enabling environment for pharmaceutical production in Africa
Interested participants should submit an abstract in one of the above four areas, of at least 250 words and not more than 300 words by 30 June 2013 by email to amrh@nepad.org and copy paul@nepadst.org and janet@nepadst.org. Abstracts must be submitted together with a complete abstract submission form, in Microsoft Word font Arial 11.5 Please download the abstract submission form available at this link [HERE/link to form] and complete it, sending it to the above email address.
Schedule of Key Dates
Deadline for Abstracts 30th June 2013
Information of Acceptance 31st July 2013
Submission of Full Papers 30thSeptember 2013
Submission of PowerPoints 31st October 2013
Conference Dates 2-3 December 2013
When submitting abstracts, those who would like to apply for financial support to attend the conference should indicate this in the abstract submission forms. Communication will be entered with only those whose abstracts have been accepted. Abstracts that are submitted after the submission deadline will not be considered and the organizers will not be held responsible for any such late submissions. All abstracts must be submitted in either English or French or both. They must also meet the word number and font requirements. Abstracts submitted in a different language will not be considered and the organizers will not be held responsible for not considering any such abstracts. Submitted abstracts that are accepted may be published by the conference organizers in a Book of Abstracts and reference will be made to the source of the abstracts. Due to limited time available for oral presentations during the conference, some of the abstracts that are accepted may only be published in the book of abstracts.
Conference Registration:
All aspiring participants are expected to register by 25 October, 2013 by sending an email to: nthabiseng@nepadst.org or call +27 12 841 2833. There is a registration fee of US$50.
Registration is free of charge for presenters.
For more details on payment for registration, Cancellation Policy; Terms of cancellation Policy; accommodation, flight, and venue, please email: nthabiseng@nepadst.org .
We look forward to receiving your abstracts at the earliest.
Regards,
Nthabiseng Legodi
Administrative Assistant
African Medicines Regulatory Harmonisation
NEPAD Planning and Coordinating Agency
email: nthabiseng@nepadst.org |
website: www.amrh.org
tel: +27 12 841 2833
1st floor, Building 10F, CSIR, Meiring Naude Road, Brummeria, Pretoria, RSA